
In a significant move to streamline its operations and focus on its cutting-edge laboratory information management system (LIMS), Labbit has announced the retirement of the Semaphore Solutions brand. This strategic decision marks a new chapter for the company as it concentrates solely on its modern LIMS platform, designed to cater to the complex needs of regulated laboratories.
Labbitt's journey began over a decade ago when the team, then known as Semaphore Solutions, started implementing laboratory systems for various regulated labs. Through this experience, they gained invaluable insights into the challenges labs face and the limitations of existing LIMS platforms. This understanding laid the foundation for the development of Labbit, a platform built from the ground up to address these shortcomings and provide a more adaptable, efficient, and user-friendly solution for laboratories.
The move to retire the Semaphore Solutions brand and consolidate operations under Labbit is a natural progression, following the company's decision over a year ago to shift its focus from professional services across multiple LIMS platforms to dedicating its full resources to Labbit. This strategic shift allows Labbit to operate as a unified entity, leveraging its expertise and knowledge to deliver laboratory informatics software tailored to the specific needs of molecular diagnostics, cell and gene therapy, manufacturing quality control, and pharma research and development.
At the heart of Labbit's platform is its innovative architecture, which utilizes visual BPMN workflow modeling and a knowledge graph database. This design enables laboratories to configure, execute, and update complex processes without the need for vendor development cycles, offering unparalleled flexibility and efficiency. According to Peter Smith, CEO of Labbit, the decision to retire the Semaphore name reflects the company's complete commitment to Labbit, both in terms of services and product development.
Labbitt's impact is already being felt in high-complexity, high-throughput laboratories, including Helix, Veracyte, and BillionToOne, where it supports workflows across clinical diagnostics, molecular testing, and precision medicine. The platform is particularly adept at handling complex biologic workflows, GMP environments, and quality control process digitalization, boasting regulatory and security credentials such as 21 CFR Part 11 readiness, SOC 2 Type II certification, and HIPAA compliance.
The consolidation under the Labbit name does not signal any changes for existing customers and partners, who will continue to receive the same level of service, support, and interaction with the team they have come to trust. The Semaphore Solutions website now redirects to Labbit, symbolizing the brand's evolution and renewed focus.
Labbitt's story is one of evolution and dedication to improving laboratory informatics. Founded in Canada as Semaphore Solutions, the company has grown to have staff across North America, drawing on decades of practical experience in laboratory informatics to deliver a platform that is purpose-built for the modern laboratory environment. As Labbit moves forward, its commitment to innovation, customer satisfaction, and regulatory compliance is set to redefine the landscape of laboratory information management systems.
Labbitt retires the Semaphore Solutions brand to focus on its modern LIMS platform.
The company's platform is designed for regulated laboratories running complex workflows in molecular diagnostics, cell and gene therapy, and quality control manufacturing.
Labbitt's architecture utilizes visual BPMN workflow modeling and a knowledge graph database for flexibility and efficiency.
The platform supports complex biologic workflows, GMP environments, and quality control process digitalization with strong regulatory and security credentials.
Existing customers and partners will experience no changes in service, support, or team interaction following the brand consolidation.